Untangling the ErbB signalling network
Yosef Yarden, Mark X. Sliwkowski · Nature Reviews Molecular Cell Biology · 2001
Cited by 6,952 works. doi:10.1038/35052073
Authors
References
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu Oncogene
- Multinational Study of the Efficacy and Safety of Humanized Anti-HER2 Monoclonal Antibody in Women Who Have HER2-Overexpressing Metastatic Breast Cancer That Has Progressed After Chemotherapy for Metastatic Disease
- Epidermal growth factor-related peptides and their receptors in human malignancies
- Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer.
- Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets
- Targeted Disruption of Mouse EGF receptor: Effect of Genetic Background on Mutant Phenotype
- c-erbB-2 Expression and Response to Adjuvant Therapy in Women with Node-Positive Early Breast Cancer
- Human epidermal growth factor: isolation and chemical and biological properties.
- Tyrosine Kinase Inhibition: An Approach to Drug Development
- The ErbB signaling network: receptor heterodimerization in development and cancer